UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000055099 |
|---|---|
| Receipt number | R000062944 |
| Scientific Title | Efficacy and safety of nanoparticle albumin-bound paclitaxel plus bevacizumab after immune checkpoint inhibitor therapy in patients with advanced non-squamous non-small cell lung cancer: a phase II trial |
| Date of disclosure of the study information | 2024/07/29 |
| Last modified on | 2026/01/27 10:47:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2024/07/29 15:07:41 | ||
| 2 | Update | 2024/09/04 20:05:13 | Co-sponsor Co-sponsor Institutions |
|
| 3 | Update | 2024/10/18 14:48:48 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2026/01/27 10:35:42 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 5 | Update | 2026/01/27 10:36:33 | Condition Condition Narrative objectives1 Narrative objectives1 |
|
| 6 | Update | 2026/01/27 10:45:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
| 7 | Update | 2026/01/27 10:47:59 | Co-sponsor Co-sponsor Institutions |
